Clinical Trial Results:
Duration of motor response after administration of experimental levodopa/carbidopa/entacapone treatment regimens compared to standard treatment (Stalevo®); a randomised, double-blind, crossover, multicentre, single dose study in patients with Parkinson’s disease and wearing-off symptoms
Summary
|
|
EudraCT number |
2010-022915-21 |
Trial protocol |
FI SE |
Global completion date |
25 Jul 2011
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
07 Sep 2016
|
First version publication date |
07 Sep 2016
|
Other versions |
|
Summary report(s) |
DURATION OF MOTOR RESPONSE AFTER ADMINISTRATION OF EXPERIMENTAL |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.